BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 30124469)

  • 1. Constitutive activation of WASp in X-linked neutropenia renders neutrophils hyperactive.
    Keszei M; Record J; Kritikou JS; Wurzer H; Geyer C; Thiemann M; Drescher P; Brauner H; Köcher L; James J; He M; Baptista MA; Dahlberg CI; Biswas A; Lane DP; Song W; Pütsep K; Vandenberghe P; Snapper SB; Westerberg LS
    J Clin Invest; 2018 Aug; 128(9):4115-4131. PubMed ID: 30124469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mouse homolog of the mutant WASp responsible for human X-linked neutropenia renders granulopoiesis ineffective.
    Ikeda M; Futami M; Chanda B; Kobayashi M; Izawa K; Tojo A
    Biochem Biophys Res Commun; 2022 Sep; 622():177-183. PubMed ID: 35932529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The open conformation of WASP regulates its nuclear localization and gene transcription in myeloid cells.
    Looi CY; Sasahara Y; Watanabe Y; Satoh M; Hakozaki I; Uchiyama M; Wong WF; Du W; Uchiyama T; Kumaki S; Tsuchiya S; Kure S
    Int Immunol; 2014 Jun; 26(6):341-52. PubMed ID: 24402308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activating WASP mutations associated with X-linked neutropenia result in enhanced actin polymerization, altered cytoskeletal responses, and genomic instability in lymphocytes.
    Westerberg LS; Meelu P; Baptista M; Eston MA; Adamovich DA; Cotta-de-Almeida V; Seed B; Rosen MK; Vandenberghe P; Thrasher AJ; Klein C; Alt FW; Snapper SB
    J Exp Med; 2010 Jun; 207(6):1145-52. PubMed ID: 20513746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overactive WASp in X-linked neutropenia leads to aberrant B-cell division and accelerated plasma cell generation.
    He M; Saeed MB; Record J; Keszei M; Gonçalves Pinho L; Vasconcelos-Fontes L; D'Aulerio R; Vieira R; Oliveira MMS; Geyer C; Bohaumilitzky L; Thiemann M; Deordieva E; Buedts L; Matias Lopes JP; Pershin D; Hammarström L; Xia Y; Zhao X; Cunningham-Rundles C; Thrasher AJ; Burns SO; Cotta-de-Almeida V; Liu C; Shcherbina A; Vandenberghe P; Westerberg LS
    J Allergy Clin Immunol; 2022 Mar; 149(3):1069-1084. PubMed ID: 34384840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations of the Wiskott-Aldrich Syndrome Protein affect protein expression and dictate the clinical phenotypes.
    Ochs HD
    Immunol Res; 2009; 44(1-3):84-8. PubMed ID: 19082760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modelling of human Wiskott-Aldrich syndrome protein mutants in zebrafish larvae using in vivo live imaging.
    Jones RA; Feng Y; Worth AJ; Thrasher AJ; Burns SO; Martin P
    J Cell Sci; 2013 Sep; 126(Pt 18):4077-84. PubMed ID: 23868979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A large kindred with X-linked neutropenia with an I294T mutation of the Wiskott-Aldrich syndrome gene.
    Beel K; Cotter MM; Blatny J; Bond J; Lucas G; Green F; Vanduppen V; Leung DW; Rooney S; Smith OP; Rosen MK; Vandenberghe P
    Br J Haematol; 2009 Jan; 144(1):120-6. PubMed ID: 19006568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. X-linked thrombocytopenia causing mutations in WASP (L46P and A47D) impair T cell chemotaxis.
    Jain N; Tan JH; Feng S; George B; Thanabalu T
    J Biomed Sci; 2014 Sep; 21(1):91. PubMed ID: 25200405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled WASp activity regulates the proliferative response for Treg cell differentiation in the thymus.
    Vasconcelos-Fontes L; Vieira RC; He M; Ferreira-Reis R; Jurberg AD; Arêas Mendes-da-Cruz D; Andersson J; Cotta-de-Almeida V; Westerberg LS
    Eur J Immunol; 2024 May; 54(5):e2350450. PubMed ID: 38356202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia.
    Devriendt K; Kim AS; Mathijs G; Frints SG; Schwartz M; Van Den Oord JJ; Verhoef GE; Boogaerts MA; Fryns JP; You D; Rosen MK; Vandenberghe P
    Nat Genet; 2001 Mar; 27(3):313-7. PubMed ID: 11242115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excess F-actin mechanically impedes mitosis leading to cytokinesis failure in X-linked neutropenia by exceeding Aurora B kinase error correction capacity.
    Moulding DA; Moeendarbary E; Valon L; Record J; Charras GT; Thrasher AJ
    Blood; 2012 Nov; 120(18):3803-11. PubMed ID: 22972986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two novel activating mutations in the Wiskott-Aldrich syndrome protein result in congenital neutropenia.
    Ancliff PJ; Blundell MP; Cory GO; Calle Y; Worth A; Kempski H; Burns S; Jones GE; Sinclair J; Kinnon C; Hann IM; Gale RE; Linch DC; Thrasher AJ
    Blood; 2006 Oct; 108(7):2182-9. PubMed ID: 16804117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutive activation of WASp leads to abnormal cytotoxic cells with increased granzyme B and degranulation response to target cells.
    Kritikou JS; Oliveira MM; Record J; Saeed MB; Nigam SM; He M; Keszei M; Wagner AK; Brauner H; Sendel A; Sedimbi SK; Rentouli S; Lane DP; Snapper SB; Kärre K; Vandenberghe P; Orange JS; Westerberg LS
    JCI Insight; 2021 Mar; 6(6):. PubMed ID: 33621210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The WASp L272P gain-of-function mutation alters dendritic cell coordination of actin dynamics for migration and adhesion.
    Oliveira MMS; Kung SY; Moreau HD; Maurin M; Record J; Sanséau D; Nylén S; Lennon-Duménil AM; Westerberg LS
    J Leukoc Biol; 2022 Apr; 111(4):793-803. PubMed ID: 34431547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unregulated actin polymerization by WASp causes defects of mitosis and cytokinesis in X-linked neutropenia.
    Moulding DA; Blundell MP; Spiller DG; White MR; Cory GO; Calle Y; Kempski H; Sinclair J; Ancliff PJ; Kinnon C; Jones GE; Thrasher AJ
    J Exp Med; 2007 Sep; 204(9):2213-24. PubMed ID: 17724125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A gain-of-function variant in the Wiskott-Aldrich syndrome gene is associated with a MYH9-related disease-like syndrome.
    Marx D; Dupuis A; Eckly A; Molitor A; Olagne J; Touchard G; Kaaki S; Ory C; Faller AL; Gérard B; Cotter M; Westerberg L; Keszei M; Moulin B; Gachet C; Caillard S; Bahram S; Carapito R
    Blood Adv; 2022 Sep; 6(18):5279-5284. PubMed ID: 35404999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotype-based gene analysis allowed successful diagnosis of X-linked neutropenia associated with a novel WASp mutation.
    Kobayashi M; Yokoyama K; Shimizu E; Yusa N; Ito M; Yamaguchi R; Imoto S; Miyano S; Tojo A
    Ann Hematol; 2018 Feb; 97(2):367-369. PubMed ID: 28956125
    [No Abstract]   [Full Text] [Related]  

  • 19. Phosphorylation of WASp is a key regulator of activity and stability in vivo.
    Blundell MP; Bouma G; Metelo J; Worth A; Calle Y; Cowell LA; Westerberg LS; Moulding DA; Mirando S; Kinnon C; Cory GO; Jones GE; Snapper SB; Burns SO; Thrasher AJ
    Proc Natl Acad Sci U S A; 2009 Sep; 106(37):15738-43. PubMed ID: 19805221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cdc42 regulates Fc gamma receptor-mediated phagocytosis through the activation and phosphorylation of Wiskott-Aldrich syndrome protein (WASP) and neural-WASP.
    Park H; Cox D
    Mol Biol Cell; 2009 Nov; 20(21):4500-8. PubMed ID: 19741094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.